Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort.
Saved in:
| Title: | Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort. |
|---|---|
| Authors: | Trottier B; Département de Recherche, Clinique de Médecine Urbaine du Quartier Latin, Montreal, QC, Canada., Yang CJ; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Watanabe D; AIDS Medical Center, NHO Osaka National Hospital, Osaka, Japan., Marchetti G; Department of Health Sciences, University of Milan, Milan, Italy., Elbirt D; Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., De Barra E; Department of International Health and Tropical Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, Ireland., Gündüz A; Department of Infectious Diseases and Clinical Microbiology, Başakşehir Çam and Sakura City Training and Research Hospital, University of Health Sciences, Istanbul, Turkey., Lee SH; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan, Republic of Korea., Vogelmann R; Mannheimer Onkologie-Praxis, Mannheim, Germany.; Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Robineau O; EA2694, University of Lille, Centre Hospitalier de Tourcoing, Tourcoing, France., Choy CY; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Berrevoets M; Department of Internal Medicine and Infectious Diseases, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands., Uriel A; Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, UK., Thorpe D; Global HIV Medical Affairs, Gilead Sciences Europe Ltd, Uxbridge, UK., Heinzkill M; Medical Affairs, Gilead Sciences GmbH, Martinsried, Germany., Marongiu A; Real World Evidence, Gilead Sciences Europe Ltd, Stockley Park, Uxbridge, UK., Ramroth J; Real World Evidence, Gilead Sciences Europe Ltd, Stockley Park, Uxbridge, UK., D'Amato L; Clinical Operations, Gilead Sciences Srl, Milan, Italy., Mallolas J; HIV Unit, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. |
| Source: | HIV research & clinical practice [HIV Res Clin Pract] 2025 Dec; Vol. 26 (1), pp. 2456890. Date of Electronic Publication: 2025 Feb 12. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Group Country of Publication: England NLM ID: 101738312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-7470 (Electronic) Linking ISSN: 25787470 NLM ISO Abbreviation: HIV Res Clin Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39936702 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Trottier+B%22">Trottier B</searchLink>; Département de Recherche, Clinique de Médecine Urbaine du Quartier Latin, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Yang+CJ%22">Yang CJ</searchLink>; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Watanabe+D%22">Watanabe D</searchLink>; AIDS Medical Center, NHO Osaka National Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Marchetti+G%22">Marchetti G</searchLink>; Department of Health Sciences, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Elbirt+D%22">Elbirt D</searchLink>; Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22De+Barra+E%22">De Barra E</searchLink>; Department of International Health and Tropical Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Gündüz+A%22">Gündüz A</searchLink>; Department of Infectious Diseases and Clinical Microbiology, Başakşehir Çam and Sakura City Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Lee+SH%22">Lee SH</searchLink>; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Vogelmann+R%22">Vogelmann R</searchLink>; Mannheimer Onkologie-Praxis, Mannheim, Germany.; Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Robineau+O%22">Robineau O</searchLink>; EA2694, University of Lille, Centre Hospitalier de Tourcoing, Tourcoing, France.<br /><searchLink fieldCode="AU" term="%22Choy+CY%22">Choy CY</searchLink>; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Berrevoets+M%22">Berrevoets M</searchLink>; Department of Internal Medicine and Infectious Diseases, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.<br /><searchLink fieldCode="AU" term="%22Uriel+A%22">Uriel A</searchLink>; Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Thorpe+D%22">Thorpe D</searchLink>; Global HIV Medical Affairs, Gilead Sciences Europe Ltd, Uxbridge, UK.<br /><searchLink fieldCode="AU" term="%22Heinzkill+M%22">Heinzkill M</searchLink>; Medical Affairs, Gilead Sciences GmbH, Martinsried, Germany.<br /><searchLink fieldCode="AU" term="%22Marongiu+A%22">Marongiu A</searchLink>; Real World Evidence, Gilead Sciences Europe Ltd, Stockley Park, Uxbridge, UK.<br /><searchLink fieldCode="AU" term="%22Ramroth+J%22">Ramroth J</searchLink>; Real World Evidence, Gilead Sciences Europe Ltd, Stockley Park, Uxbridge, UK.<br /><searchLink fieldCode="AU" term="%22D'Amato+L%22">D'Amato L</searchLink>; Clinical Operations, Gilead Sciences Srl, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mallolas+J%22">Mallolas J</searchLink>; HIV Unit, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101738312%22">HIV research & clinical practice</searchLink> [HIV Res Clin Pract] 2025 Dec; Vol. 26 (1), pp. 2456890. <i>Date of Electronic Publication: </i>2025 Feb 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis+Group%22">Taylor & Francis Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101738312 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2578-7470 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225787470%22">25787470 </searchLink><i>NLM ISO Abbreviation: </i>HIV Res Clin Pract <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39936702 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/25787489.2025.2456890 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2456890 Titles: – TitleFull: Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Trottier B – PersonEntity: Name: NameFull: Yang CJ – PersonEntity: Name: NameFull: Watanabe D – PersonEntity: Name: NameFull: Marchetti G – PersonEntity: Name: NameFull: Elbirt D – PersonEntity: Name: NameFull: De Barra E – PersonEntity: Name: NameFull: Gündüz A – PersonEntity: Name: NameFull: Lee SH – PersonEntity: Name: NameFull: Vogelmann R – PersonEntity: Name: NameFull: Robineau O – PersonEntity: Name: NameFull: Choy CY – PersonEntity: Name: NameFull: Berrevoets M – PersonEntity: Name: NameFull: Uriel A – PersonEntity: Name: NameFull: Thorpe D – PersonEntity: Name: NameFull: Heinzkill M – PersonEntity: Name: NameFull: Marongiu A – PersonEntity: Name: NameFull: Ramroth J – PersonEntity: Name: NameFull: D'Amato L – PersonEntity: Name: NameFull: Mallolas J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2578-7470 Numbering: – Type: volume Value: 26 – Type: issue Value: 1 Titles: – TitleFull: HIV research & clinical practice Type: main |
| ResultId | 1 |
